Vulvar melanoma: A retrospective analysis and literature review

Gynecologic Oncology

Volumn 83, Issue 3, 2001, Pages 457-465

  Irvin Jr , William P ^a   Legallo, Robin L ^a   Stoler, Mark H ^a   Rice, Laurel W ^a   Taylor Jr , Peyton T ^a   Andersen, Willie A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Malignant melanoma; Microstaging; Sentinel lymph node

Indexed keywords

ADULT; AGED; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; VULVA CARCINOMA;

EID: 0035213003     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6337     Document Type: Review

References (50)

1. Current management of vulvar melanoma
2. Malignant melanoma of the genitourinary tract
3. A clinicopathologic study of 30 melanomas of the vulva
4. Sequel to a case of recurrent melanosis of both groins and back: The disease reappearing in the brain, heart, pancreas, liver and other organs
5. A survey of hospital management practices for vulvar melanoma
6. Malignant melanoma of the vulva: A clinicopathologic study of 18 cases
7. Melanoma of the vulva: An update
8. Malignant melanoma
9. Malignant melanoma of the female genitalia
10. Surgery for vulvar cancer
11. Malignant melanoma of the vulva
12. Review and current perspectives of cutaneous malignant melanoma
13. Conservative therapy for melanoma of the vulva
14. Malignant melanoma of the vulva: A clinicopathological study of 50 women
15. Management of vulvar melanoma
16. Malignant melanoma of the vulva: Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients
17. Paget's disease and melanoma of the vulva
18. Malignant melanoma of the vulva: Australian experience
19. Malignant melanoma of the vulva: Clinicopathological features
20. Malignant melanoma of the female genital system: A report of 48 patients and review of the literature
21. Malignant melanoma of the vulva treated by radical hemivulvectomy: A prospective study of the Gynecologic Oncology Group
22. The histogenesis and biologic behavior of primary human malignant melanomas of the skin
23. Thickness, cross-sectional areas, and depth of invasion in the prognosis of cutaneous melanoma
24. Vulvo-vaginal melanoma: Should radical surgery be abandoned?
25. Malignant melanoma of the vulva
26. Malignant melanoma of the vulva and vagina
27. Vulvar melanoma reconsidered
28. The recovery pattern of patients with vulvar melanoma treated by combined surgery and radiation therapy
29. Melanomas of the vulva and vagina
30. Efficacy of 2-cm surgical margins for intermediate thickness melanomas (1-4 mm): Results of a multi-institutional randomized surgical trial
31. Narrow excision (1 cm margin): A safe procedure for thin cutaneous melanoma
32. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma
33. Surgical management of regional lymph nodes in patients with melanoma: Experience with 4682 patients
34. A comparison of prognostic factors and surgical results in 1786 patients with localized (Stage I) melanoma treated in Alabama, USA, and New South Wales, Australia
35. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patients
36. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma
37. Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study
38. Treatment of regional nodes
39. Technical details of intraoperative lymphatic mapping for early stage melanoma
40. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva
41. Sentinel lymph node procedure in squamous cell carcinoma of the vulva
42. Intraoperative lymphatic mapping and sentinel node identification: Gynecologic applications
43. Sentinel node localization by lymphoscintigraphy: A reliable technique with wide applications
44. Sentinel node dissection and ultrastaging in squamous cell carcinoma of the vulva
45. Interferon alpha-2b adjuvant therapy of high risk cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
46. Preliminary results of the E1690/S9111/C9190 Intergroup postoperative adjuvant trial of high- and lowdose IFN a2b (HDI and LDI) in high-risk primary or lymph node static melanoma
47. High-dose interferon alpha-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIb-III melanoma: Results of Intergroup Trial E1694/S9512/C509801
48. Treatment of human melanoma with a hapten-modified autologous vaccine
49. Malignant melanoma of the vulva: Response to radiation
50. Conservative surgery for vulvo-vaginal melanoma